False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors

ObjectiveIt is broadly accepted that the false positive (FP) rate for endoscopic ultrasound fine needle aspiration (EUS FNA) is 0–1%. It was hypothesised that the FP and false suspicious (FS) rates for EUS FNA are greater than reported. A study was undertaken to establish the rate and root cause of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2010-05, Vol.59 (5), p.586-593
Hauptverfasser: Gleeson, Ferga C, Kipp, Benjamin R, Caudill, Jill L, Clain, Jonathan E, Clayton, Amy C, Halling, Kevin C, Henry, Michael R, Rajan, Elizabeth, Topazian, Mark D, Wang, Kenneth K, Wiersema, Maurits J, Zhang, Jun, Levy, Michael J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 593
container_issue 5
container_start_page 586
container_title Gut
container_volume 59
creator Gleeson, Ferga C
Kipp, Benjamin R
Caudill, Jill L
Clain, Jonathan E
Clayton, Amy C
Halling, Kevin C
Henry, Michael R
Rajan, Elizabeth
Topazian, Mark D
Wang, Kenneth K
Wiersema, Maurits J
Zhang, Jun
Levy, Michael J
description ObjectiveIt is broadly accepted that the false positive (FP) rate for endoscopic ultrasound fine needle aspiration (EUS FNA) is 0–1%. It was hypothesised that the FP and false suspicious (FS) rates for EUS FNA are greater than reported. A study was undertaken to establish the rate and root cause of discordant interpretation.DesignUsing a prospectively maintained endoscopic database, cytohistological discordant EUS FNA examinations from 30 July 1996 to 31 December 2008 were identified retrospectively.SettingTertiary referral centre.Main outcome measuresDiscordant FNA was defined by positive or suspicious FNA cytology in the absence of malignancy or neoplasm in the subsequent surgical pathology specimen, specifically in the absence of neoadjuvant therapy. Three cytopathologists conducted a blinded review of randomised discordant and matched specimens.ResultsFNA was performed in 5667/18 066 (31.4%) patients undergoing EUS, of whom 2547 had cytology results interpreted as ‘positive’ or ‘suspicious’ or ‘atypical’ for malignancy or neoplasm. Subsequent surgical resection without prior neoadjuvant therapy was performed in 377 patients with positive or suspicious cytology. The FP rate was 20/377 (5.3%) and increased to 27/377 (7.2%) when FS cases were included. The incidence of discordance was consistent over time (1996–2002: 10/118 (8.6%) vs 2003–2008: 17/259 (6.6%); p=0.5) and was higher in non-pancreatic FNA (15%) than pancreatic FNA (2.2%; p=0.0001). Two-thirds of the non-pancreatic FP cases involved sampling of perioesophageal or perirectal nodes in patients with luminal neoplasms or Barrett's oesophagus. Following pathological re-review, discordance was attributed to translocated cell contamination/sampling error (50%) or cytopathologist interpretive error (50%).ConclusionsThese findings refute the accepted paradigm that FP cytology rarely occurs with EUS FNA. Further investigation revealed that FP FNA developed secondary to endosonographer technique or initial cytological misinterpretation, and is particularly likely when perioesophageal or perirectal nodes are aspirated in the setting of a luminal neoplasm or Barrett's oesophagus. Further study is needed to determine the significance of these findings and potential impact on the performance of FNA and patient outcomes.
doi_str_mv 10.1136/gut.2009.187765
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733929628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733929628</sourcerecordid><originalsourceid>FETCH-LOGICAL-b493t-f5a636d5e03ccbe633e45871cab2d33b12f50033ea5b994ceef2018af258c3763</originalsourceid><addsrcrecordid>eNqF0M9rFDEUB_Agil2rZ28yIFIQZpsfk1-96daqUPSi4i1mMm9KtrPJmMwU9783y6wVvHgK5H3y3ssXoecErwlh4vxmntYUY70mSkrBH6AVaYSqGVXqIVphTGTNZaNP0JOctxhjpTR5jE4obqhkmq7Qjys7ZKjGmP3k76CC0MXs4uhdNQ9TsjnOoat6H6AKAN0Alc2jT3byMVRuP8Uh3uwvKh-c7yC4Ui48-Xxb9dZNMeWn6FF_GPHseJ6ir1fvvmw-1Nef33_cvLmu20azqe65FUx0HDBzrgXBGDRcSeJsSzvGWkJ7jnG5tbzVunEAPcVE2Z5y5ZgU7BSdLX3HFH_OkCez89nBMNgAcc5GsvJfLagq8uU_chvnFMpyhkipWcMlZUWdL8qlmHOC3ozJ72zaG4LNIXtTsjeH7M2SfXnx4th3bnfQ3fs_YRfw6ghsdnboky2p5b-OSlFmN8XVi_N5gl_3dZtujZBMcvPp28bgS6q-87fKXBb_evHtbvvfLX8Dw1qpRw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779345723</pqid></control><display><type>article</type><title>False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>PubMed Central</source><creator>Gleeson, Ferga C ; Kipp, Benjamin R ; Caudill, Jill L ; Clain, Jonathan E ; Clayton, Amy C ; Halling, Kevin C ; Henry, Michael R ; Rajan, Elizabeth ; Topazian, Mark D ; Wang, Kenneth K ; Wiersema, Maurits J ; Zhang, Jun ; Levy, Michael J</creator><creatorcontrib>Gleeson, Ferga C ; Kipp, Benjamin R ; Caudill, Jill L ; Clain, Jonathan E ; Clayton, Amy C ; Halling, Kevin C ; Henry, Michael R ; Rajan, Elizabeth ; Topazian, Mark D ; Wang, Kenneth K ; Wiersema, Maurits J ; Zhang, Jun ; Levy, Michael J</creatorcontrib><description>ObjectiveIt is broadly accepted that the false positive (FP) rate for endoscopic ultrasound fine needle aspiration (EUS FNA) is 0–1%. It was hypothesised that the FP and false suspicious (FS) rates for EUS FNA are greater than reported. A study was undertaken to establish the rate and root cause of discordant interpretation.DesignUsing a prospectively maintained endoscopic database, cytohistological discordant EUS FNA examinations from 30 July 1996 to 31 December 2008 were identified retrospectively.SettingTertiary referral centre.Main outcome measuresDiscordant FNA was defined by positive or suspicious FNA cytology in the absence of malignancy or neoplasm in the subsequent surgical pathology specimen, specifically in the absence of neoadjuvant therapy. Three cytopathologists conducted a blinded review of randomised discordant and matched specimens.ResultsFNA was performed in 5667/18 066 (31.4%) patients undergoing EUS, of whom 2547 had cytology results interpreted as ‘positive’ or ‘suspicious’ or ‘atypical’ for malignancy or neoplasm. Subsequent surgical resection without prior neoadjuvant therapy was performed in 377 patients with positive or suspicious cytology. The FP rate was 20/377 (5.3%) and increased to 27/377 (7.2%) when FS cases were included. The incidence of discordance was consistent over time (1996–2002: 10/118 (8.6%) vs 2003–2008: 17/259 (6.6%); p=0.5) and was higher in non-pancreatic FNA (15%) than pancreatic FNA (2.2%; p=0.0001). Two-thirds of the non-pancreatic FP cases involved sampling of perioesophageal or perirectal nodes in patients with luminal neoplasms or Barrett's oesophagus. Following pathological re-review, discordance was attributed to translocated cell contamination/sampling error (50%) or cytopathologist interpretive error (50%).ConclusionsThese findings refute the accepted paradigm that FP cytology rarely occurs with EUS FNA. Further investigation revealed that FP FNA developed secondary to endosonographer technique or initial cytological misinterpretation, and is particularly likely when perioesophageal or perirectal nodes are aspirated in the setting of a luminal neoplasm or Barrett's oesophagus. Further study is needed to determine the significance of these findings and potential impact on the performance of FNA and patient outcomes.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>DOI: 10.1136/gut.2009.187765</identifier><identifier>PMID: 20427392</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Accuracy ; Biological and medical sciences ; Biopsy, Fine-Needle - standards ; Biopsy, Fine-Needle - statistics &amp; numerical data ; Cancer ; Cancer therapies ; Cellular biology ; Chemotherapy ; Digestive System Neoplasms - diagnostic imaging ; Digestive System Neoplasms - pathology ; Digestive System Neoplasms - surgery ; Endoscopic ultrasonography ; endoscopic ultrasound fine needle aspiration ; Endoscopy ; Endosonography - standards ; Endosonography - statistics &amp; numerical data ; Epidemiologic Methods ; EUS FNA ; false positive cytology ; False Positive Reactions ; false suspicious cytology ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Medical sciences ; Metastasis ; Minnesota ; Pancreatic Neoplasms - pathology ; Pathology ; Studies ; Thyroid gland ; Tumors ; Ultrasonic imaging ; Ultrasonography, Interventional - standards ; Ultrasonography, Interventional - statistics &amp; numerical data ; Workload</subject><ispartof>Gut, 2010-05, Vol.59 (5), p.586-593</ispartof><rights>2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b493t-f5a636d5e03ccbe633e45871cab2d33b12f50033ea5b994ceef2018af258c3763</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://gut.bmj.com/content/59/5/586.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://gut.bmj.com/content/59/5/586.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77343,77374</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22764574$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20427392$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gleeson, Ferga C</creatorcontrib><creatorcontrib>Kipp, Benjamin R</creatorcontrib><creatorcontrib>Caudill, Jill L</creatorcontrib><creatorcontrib>Clain, Jonathan E</creatorcontrib><creatorcontrib>Clayton, Amy C</creatorcontrib><creatorcontrib>Halling, Kevin C</creatorcontrib><creatorcontrib>Henry, Michael R</creatorcontrib><creatorcontrib>Rajan, Elizabeth</creatorcontrib><creatorcontrib>Topazian, Mark D</creatorcontrib><creatorcontrib>Wang, Kenneth K</creatorcontrib><creatorcontrib>Wiersema, Maurits J</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><creatorcontrib>Levy, Michael J</creatorcontrib><title>False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors</title><title>Gut</title><addtitle>Gut</addtitle><description>ObjectiveIt is broadly accepted that the false positive (FP) rate for endoscopic ultrasound fine needle aspiration (EUS FNA) is 0–1%. It was hypothesised that the FP and false suspicious (FS) rates for EUS FNA are greater than reported. A study was undertaken to establish the rate and root cause of discordant interpretation.DesignUsing a prospectively maintained endoscopic database, cytohistological discordant EUS FNA examinations from 30 July 1996 to 31 December 2008 were identified retrospectively.SettingTertiary referral centre.Main outcome measuresDiscordant FNA was defined by positive or suspicious FNA cytology in the absence of malignancy or neoplasm in the subsequent surgical pathology specimen, specifically in the absence of neoadjuvant therapy. Three cytopathologists conducted a blinded review of randomised discordant and matched specimens.ResultsFNA was performed in 5667/18 066 (31.4%) patients undergoing EUS, of whom 2547 had cytology results interpreted as ‘positive’ or ‘suspicious’ or ‘atypical’ for malignancy or neoplasm. Subsequent surgical resection without prior neoadjuvant therapy was performed in 377 patients with positive or suspicious cytology. The FP rate was 20/377 (5.3%) and increased to 27/377 (7.2%) when FS cases were included. The incidence of discordance was consistent over time (1996–2002: 10/118 (8.6%) vs 2003–2008: 17/259 (6.6%); p=0.5) and was higher in non-pancreatic FNA (15%) than pancreatic FNA (2.2%; p=0.0001). Two-thirds of the non-pancreatic FP cases involved sampling of perioesophageal or perirectal nodes in patients with luminal neoplasms or Barrett's oesophagus. Following pathological re-review, discordance was attributed to translocated cell contamination/sampling error (50%) or cytopathologist interpretive error (50%).ConclusionsThese findings refute the accepted paradigm that FP cytology rarely occurs with EUS FNA. Further investigation revealed that FP FNA developed secondary to endosonographer technique or initial cytological misinterpretation, and is particularly likely when perioesophageal or perirectal nodes are aspirated in the setting of a luminal neoplasm or Barrett's oesophagus. Further study is needed to determine the significance of these findings and potential impact on the performance of FNA and patient outcomes.</description><subject>Accuracy</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Fine-Needle - standards</subject><subject>Biopsy, Fine-Needle - statistics &amp; numerical data</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Digestive System Neoplasms - diagnostic imaging</subject><subject>Digestive System Neoplasms - pathology</subject><subject>Digestive System Neoplasms - surgery</subject><subject>Endoscopic ultrasonography</subject><subject>endoscopic ultrasound fine needle aspiration</subject><subject>Endoscopy</subject><subject>Endosonography - standards</subject><subject>Endosonography - statistics &amp; numerical data</subject><subject>Epidemiologic Methods</subject><subject>EUS FNA</subject><subject>false positive cytology</subject><subject>False Positive Reactions</subject><subject>false suspicious cytology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metastasis</subject><subject>Minnesota</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pathology</subject><subject>Studies</subject><subject>Thyroid gland</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonography, Interventional - standards</subject><subject>Ultrasonography, Interventional - statistics &amp; numerical data</subject><subject>Workload</subject><issn>0017-5749</issn><issn>1468-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqF0M9rFDEUB_Agil2rZ28yIFIQZpsfk1-96daqUPSi4i1mMm9KtrPJmMwU9783y6wVvHgK5H3y3ssXoecErwlh4vxmntYUY70mSkrBH6AVaYSqGVXqIVphTGTNZaNP0JOctxhjpTR5jE4obqhkmq7Qjys7ZKjGmP3k76CC0MXs4uhdNQ9TsjnOoat6H6AKAN0Alc2jT3byMVRuP8Uh3uwvKh-c7yC4Ui48-Xxb9dZNMeWn6FF_GPHseJ6ir1fvvmw-1Nef33_cvLmu20azqe65FUx0HDBzrgXBGDRcSeJsSzvGWkJ7jnG5tbzVunEAPcVE2Z5y5ZgU7BSdLX3HFH_OkCez89nBMNgAcc5GsvJfLagq8uU_chvnFMpyhkipWcMlZUWdL8qlmHOC3ozJ72zaG4LNIXtTsjeH7M2SfXnx4th3bnfQ3fs_YRfw6ghsdnboky2p5b-OSlFmN8XVi_N5gl_3dZtujZBMcvPp28bgS6q-87fKXBb_evHtbvvfLX8Dw1qpRw</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Gleeson, Ferga C</creator><creator>Kipp, Benjamin R</creator><creator>Caudill, Jill L</creator><creator>Clain, Jonathan E</creator><creator>Clayton, Amy C</creator><creator>Halling, Kevin C</creator><creator>Henry, Michael R</creator><creator>Rajan, Elizabeth</creator><creator>Topazian, Mark D</creator><creator>Wang, Kenneth K</creator><creator>Wiersema, Maurits J</creator><creator>Zhang, Jun</creator><creator>Levy, Michael J</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors</title><author>Gleeson, Ferga C ; Kipp, Benjamin R ; Caudill, Jill L ; Clain, Jonathan E ; Clayton, Amy C ; Halling, Kevin C ; Henry, Michael R ; Rajan, Elizabeth ; Topazian, Mark D ; Wang, Kenneth K ; Wiersema, Maurits J ; Zhang, Jun ; Levy, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b493t-f5a636d5e03ccbe633e45871cab2d33b12f50033ea5b994ceef2018af258c3763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Accuracy</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Fine-Needle - standards</topic><topic>Biopsy, Fine-Needle - statistics &amp; numerical data</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Digestive System Neoplasms - diagnostic imaging</topic><topic>Digestive System Neoplasms - pathology</topic><topic>Digestive System Neoplasms - surgery</topic><topic>Endoscopic ultrasonography</topic><topic>endoscopic ultrasound fine needle aspiration</topic><topic>Endoscopy</topic><topic>Endosonography - standards</topic><topic>Endosonography - statistics &amp; numerical data</topic><topic>Epidemiologic Methods</topic><topic>EUS FNA</topic><topic>false positive cytology</topic><topic>False Positive Reactions</topic><topic>false suspicious cytology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metastasis</topic><topic>Minnesota</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pathology</topic><topic>Studies</topic><topic>Thyroid gland</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonography, Interventional - standards</topic><topic>Ultrasonography, Interventional - statistics &amp; numerical data</topic><topic>Workload</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gleeson, Ferga C</creatorcontrib><creatorcontrib>Kipp, Benjamin R</creatorcontrib><creatorcontrib>Caudill, Jill L</creatorcontrib><creatorcontrib>Clain, Jonathan E</creatorcontrib><creatorcontrib>Clayton, Amy C</creatorcontrib><creatorcontrib>Halling, Kevin C</creatorcontrib><creatorcontrib>Henry, Michael R</creatorcontrib><creatorcontrib>Rajan, Elizabeth</creatorcontrib><creatorcontrib>Topazian, Mark D</creatorcontrib><creatorcontrib>Wang, Kenneth K</creatorcontrib><creatorcontrib>Wiersema, Maurits J</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><creatorcontrib>Levy, Michael J</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gleeson, Ferga C</au><au>Kipp, Benjamin R</au><au>Caudill, Jill L</au><au>Clain, Jonathan E</au><au>Clayton, Amy C</au><au>Halling, Kevin C</au><au>Henry, Michael R</au><au>Rajan, Elizabeth</au><au>Topazian, Mark D</au><au>Wang, Kenneth K</au><au>Wiersema, Maurits J</au><au>Zhang, Jun</au><au>Levy, Michael J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>59</volume><issue>5</issue><spage>586</spage><epage>593</epage><pages>586-593</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><coden>GUTTAK</coden><abstract>ObjectiveIt is broadly accepted that the false positive (FP) rate for endoscopic ultrasound fine needle aspiration (EUS FNA) is 0–1%. It was hypothesised that the FP and false suspicious (FS) rates for EUS FNA are greater than reported. A study was undertaken to establish the rate and root cause of discordant interpretation.DesignUsing a prospectively maintained endoscopic database, cytohistological discordant EUS FNA examinations from 30 July 1996 to 31 December 2008 were identified retrospectively.SettingTertiary referral centre.Main outcome measuresDiscordant FNA was defined by positive or suspicious FNA cytology in the absence of malignancy or neoplasm in the subsequent surgical pathology specimen, specifically in the absence of neoadjuvant therapy. Three cytopathologists conducted a blinded review of randomised discordant and matched specimens.ResultsFNA was performed in 5667/18 066 (31.4%) patients undergoing EUS, of whom 2547 had cytology results interpreted as ‘positive’ or ‘suspicious’ or ‘atypical’ for malignancy or neoplasm. Subsequent surgical resection without prior neoadjuvant therapy was performed in 377 patients with positive or suspicious cytology. The FP rate was 20/377 (5.3%) and increased to 27/377 (7.2%) when FS cases were included. The incidence of discordance was consistent over time (1996–2002: 10/118 (8.6%) vs 2003–2008: 17/259 (6.6%); p=0.5) and was higher in non-pancreatic FNA (15%) than pancreatic FNA (2.2%; p=0.0001). Two-thirds of the non-pancreatic FP cases involved sampling of perioesophageal or perirectal nodes in patients with luminal neoplasms or Barrett's oesophagus. Following pathological re-review, discordance was attributed to translocated cell contamination/sampling error (50%) or cytopathologist interpretive error (50%).ConclusionsThese findings refute the accepted paradigm that FP cytology rarely occurs with EUS FNA. Further investigation revealed that FP FNA developed secondary to endosonographer technique or initial cytological misinterpretation, and is particularly likely when perioesophageal or perirectal nodes are aspirated in the setting of a luminal neoplasm or Barrett's oesophagus. Further study is needed to determine the significance of these findings and potential impact on the performance of FNA and patient outcomes.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>20427392</pmid><doi>10.1136/gut.2009.187765</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2010-05, Vol.59 (5), p.586-593
issn 0017-5749
1468-3288
language eng
recordid cdi_proquest_miscellaneous_733929628
source MEDLINE; BMJ Journals - NESLi2; PubMed Central
subjects Accuracy
Biological and medical sciences
Biopsy, Fine-Needle - standards
Biopsy, Fine-Needle - statistics & numerical data
Cancer
Cancer therapies
Cellular biology
Chemotherapy
Digestive System Neoplasms - diagnostic imaging
Digestive System Neoplasms - pathology
Digestive System Neoplasms - surgery
Endoscopic ultrasonography
endoscopic ultrasound fine needle aspiration
Endoscopy
Endosonography - standards
Endosonography - statistics & numerical data
Epidemiologic Methods
EUS FNA
false positive cytology
False Positive Reactions
false suspicious cytology
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Medical sciences
Metastasis
Minnesota
Pancreatic Neoplasms - pathology
Pathology
Studies
Thyroid gland
Tumors
Ultrasonic imaging
Ultrasonography, Interventional - standards
Ultrasonography, Interventional - statistics & numerical data
Workload
title False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A39%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=False%20positive%20endoscopic%20ultrasound%20fine%20needle%20aspiration%20cytology:%20incidence%20and%20risk%20factors&rft.jtitle=Gut&rft.au=Gleeson,%20Ferga%20C&rft.date=2010-05-01&rft.volume=59&rft.issue=5&rft.spage=586&rft.epage=593&rft.pages=586-593&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.2009.187765&rft_dat=%3Cproquest_cross%3E733929628%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779345723&rft_id=info:pmid/20427392&rfr_iscdi=true